|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02373 BEAUTYFARM MED
Nominal 
18.210 +0.390 (+2.189%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 1,881,607 | 28.964% | 3,000,539 | 2,572,199 | 2,145,068 | 1,635,414 |
| Cost of Sales | (915,072) | 23.788% | (1,528,657) | (1,382,204) | (1,167,966) | (917,572) |
| Gross Profit | 966,535 | 34.281% | 1,471,882 | 1,189,995 | 977,102 | 717,842 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 247 | -- | (2,809) | (3,021) | (796) | (155) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | (51) | 0 | |
| Profit / (Loss) before Taxation | 320,182 | 45.068% | 450,066 | 317,883 | 288,269 | 130,475 | |
| Taxation | (80,811) | 61.816% | (109,791) | (65,405) | (58,130) | (19,943) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (17,215) | 14.082% | (22,713) | (24,018) | (14,482) | (7,423) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 222,156 | 42.699% | 317,562 | 228,460 | 215,657 | 103,109 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 14,353 | 320.786% | 9,450 | 3,941 | 2,974 | 21,619 |
| Depreciation & Amortisation | 240,500 | 21.957% | -- | 382,577 | 331,736 | 297,241 |
| Directors' Emoluments | -- | -- | -- | 3,819 | 3,244 | 6,124 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 91.000 | 33.824% | 138.000 | 99.000 | 94.000 | 52.000 |
| DPS (cts) | 0.000 | -- | 63.000 | 48.000 | 43.000 | 34.000 |
| Dividend Payout Ratio (%) | -- | -- | 45.652% | 48.485% | 45.745% | 65.385% |
| Cash flow per share ($) | -- | -- | 4.354 | 3.469 | 2.736 | 1.911 |
| NBV per share ($) | 5.659 | -- | 4.352 | 4.006 | 3.392 | -- |
| Remarks: | Real time quote last updated: 10/09/2026 17:52 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 222,156 |
| %Change | 42.699% |
| EPS / (LPS) | RMB 0.910 |
| NBV Per Share (¥) | RMB 5.659 |